Brief: Nordic Nanovector To Seek Regulatory Feedback After Preliminary Review

Thor Medical ASA

21/06/2022 15:37

June 21 (Reuters) - Nordic Nanovector ASA  NANOVN.OL :
    * NORDIC NANOVECTOR TO SEEK REGULATORY FEEDBACK FOLLOWING
ITS
PRELIMINARY REVIEW AND INDEPENDENT DATA EVALUATION OF PARADIGME,
ITS PHASE 2B TRIAL WITH BETALUTIN® IN R/R FOLLICULAR LYMPHOMA
    * FOLLOWING INTERACTION WITH REGULATORY AUTHORITIES, COMPANY
WILL
PROVIDE AN ADDITIONAL UPDATE, WHICH IS EXPECTED IN AUGUST
    * DOES NOW NOT EXPECT TO DELIVER PRELIMINARY TOP LINE DATA
FROM
PARADIGME IN H2 2022

Source text for Eikon:  ID:nWkr4tQsvt 
Further company coverage:  NANOVN.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))